Log-in / Create Account  
 
DIA 2013 49th Annual Meeting
Click here to go to the previous page
Measuring the Impact of Subject Dual Enrollment on Study Data Validity and a Web-based Tool to Avoid Simultaneous Participation in Multiple Concurrent Clinical Trials
Track : Track 04: Nonclinical and Translational Development/Early Phase Clinical Development
Program Code: 230
Date: Tuesday, June 25, 2013
Time: 10:15 AM to 11:45 AM  EST
Location: 105
CHAIR :
Darran Boyer, clinicalRSVPFL, United States
SPEAKER (S):
Ashish Jain, MPharm (SPKNON), VP, Early Clinical Development, Quintiles Phase One Clinical Trials India Private Limited, India
 Mary L Westrick, PhD (SPKNON), Vice President, US Phase I, Quintiles Inc., United States
 Annick Peremans, (SPKNON), General Manager, Phase 1 Unit, Research Centre Aalst, Belgium
Description
This session will evaluate methods used by researchers to measure the impact of subject dual enrollment on clinical trial study data. We will explore the scientific and economic impact of dual subject enrollment to the clinical research industry. We will also discuss steps taken by industry to mitigate subject dual enrollment and explore methods to overcome key challenges.

Session Recording
(Code: 230)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON3 Comp Access: Tuesday Online Access Package - June 25, 2013
Handout Online
(Code: 230)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON3 Comp Access: Tuesday Online Access Package - June 25, 2013
Measuring the Impact of Subject Dual Enrollment on Study Data Validity and a Web-based Tool to Avoid Simultaneous Participation in Multiple Concurrent Clinical Trials